AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 2%
#73 out of 5256 analysts
Average Return
+18.77%
Win Rate
54%221 out of 413
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | +426.92% | $2.60 | $13.70 | 2024-12-03 - 2025-12-03 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Trevi Therapeutics IncTRVI | +278.35% | $2.91 | $11.01 | 2024-11-07 - 2025-11-07 | Buy |
Trevi Therapeutics IncTRVI | +265.83% | $3.60 | $13.17 | 2024-12-11 - 2025-12-11 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viridian Therapeutics IncVRDN | 21 | Buy | $32.00 | +117.98% | Maintains | 23 days ago |
Kalvista Pharmaceuticals IncKALV | 23 | Buy | $36.00 | +72.50% | Maintains | a month ago |
Collegium Pharmaceutical IncCOLL | 25 | Buy | $56.00 | +63.22% | Reiterates | a month ago |
Trevi Therapeutics IncTRVI | 21 | Buy | $24.00 | +55.84% | Maintains | a month ago |
Xenon Pharmaceuticals IncXENE | 15 | Buy | $80.00 | +40.13% | Maintains | a month ago |
Cormedix IncCRMD | 21 | Buy | $14.00 | +84.70% | Maintains | 2 months ago |
Liquidia CorpLQDA | 35 | Buy | $54.00 | +43.39% | Maintains | 2 months ago |
Oculis Holding AgOCS | 3 | Buy | $40.00 | +39.81% | Maintains | 2 months ago |
Esperion Therapeutics IncESPR | 21 | Buy | $5.00 | +147.52% | Maintains | 2 months ago |
Amphastar Pharmaceuticals IncAMPH | 4 | Buy | $30.00 | +30.89% | Maintains | 2 months ago |
Arcutis Biotherapeutics IncARQT | 25 | Buy | $36.00 | +47.12% | Maintains | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 15 | Buy | $25.00 | +39.74% | Reiterates | 2 months ago |
Cytokinetics IncCYTK | 27 | Buy | $85.00 | +28.52% | Maintains | 2 months ago |
Ocular Therapeutix IncOCUL | 7 | Buy | $18.00 | +89.08% | Maintains | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 11 | Buy | $48.00 | +41.93% | Maintains | 2 months ago |
Pacira Biosciences IncPCRX | 28 | Buy | $30.00 | +20.48% | Maintains | 3 months ago |
Biocryst Pharmaceuticals IncBCRX | 18 | Buy | $18.00 | +95.87% | Maintains | 6 months ago |
Heron Therapeutics IncHRTX | 21 | Buy | $3.00 | +185.71% | Maintains | 8 months ago |
Evolus IncEOLS | 16 | Hold | $22.00 | +333.07% | Downgrades | 9 months ago |
Clearside Biomedical IncCLSDQ | 16 | Hold | $45.00 | +10,875.61% | Downgrades | 9 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $120.00 | N/A | Downgrades | 2 years ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 3 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 4 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $18.00 | N/A | Maintains | 5 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.